|
Die lange Durststrecke bei American Bio-med hat hoffentlich endlich ein Ende!Eine neue Nachricht,und schon ist ein deutlicher Kursanstieg zu bemerken..Allerdings gilt es trotzdem den Kurs in nächster Zeit genauer zu beobachten,ob es nun steil bergauf geht,od.ob das ganze nur als ein kurzzeitiger Ausschlag zu betrachten ist.Was meint ihr? Gruss an alle! NASiDAQ Aber hier die Nachricht,die sich ziemlich vielversprechend anhört: (http://finance.yahoo.com) Wednesday March 29, 8:32 am Eastern Time Company Press Release American BioMed Launches Distributor Alliance and Renews Shareholder Communications Through DeMonte Associates THE WOODLANDS, Texas--(BUSINESS WIRE)--March 29, 2000--American BioMed, Inc. (OTCBB:ABMI - news) today reported that it has initiated a distributor alliance with and received opening orders from the Pharmed Group of Miami, Florida. The Pharmed alliance facilitates opening of a distribution channel for sales of the Company`s silicone catheter products in Latin America and the Caribbean. Pharmed`s Vice President for International Sales, Alex Lazaro, added, ``We are very excited to be able to offer our distributor network the quality products from American BioMed. Over the next few months, we will undertake product registration in the countries with these requirements, so that full-scale promotion can proceed as soon as possible.`` Marshall Kerr, the Company`s President and Chief Operating Officer commented, ``This agreement overcomes a previous gap in our distributor network, easing our entry into a valued new geographic market. We believe this is a favorable milestone on our path from a developmental to an operating entity.`` In further news, the Company announced that it has resumed its relationship with DeMonte Associates. DeMonte Associates is a professional investor relations firm which specializes in shareholder communications on behalf of high-growth biotechnology companies. American BioMed, Inc. develops, manufactures and markets devices for minimally-invasive interventional cardiology and other surgical procedures. This release contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. While based on assumptions the Company believes are reasonable, actual results could differ materially based on changes in these or unforeseen factors, and the Company assumes no obligation to publicly update or revise any forward-looking statements herein. Among such uncertainties are government regulation; results of research, development, and clinical testing; general economic and other market conditions; pricing and reimbursement for medical care; and market competition. Please see the Company`s Securities and Exchange Commission filings for detailed discussion of such risk factors. -------------------------------------------------------------------------------- Contact: DeMonte Associates Cynthia DeMonte, 212/473-3700 |
|
| aus der Diskussion: | Neue Nachricht bei American Bio-med!!!! |
| Autor (Datum des Eintrages): | NASiDAQ (29.03.00 18:45:29) |
| Beitrag: | 1 von 1 (ID:718105) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |